Filter
470
Text search:
Pharmaceutical
Prices
Featured
Recommendations
36
New Publications
135
Language
Document type
No document type
239
Studies & Reports
124
Guidelines
48
Strategic & Response Plan
24
Manuals
16
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
1
Countries / Regions
India
21
Global
18
Kenya
16
Uganda
14
Sierra Leone
9
Ghana
9
Ukraine
9
Liberia
8
Nigeria
8
Zambia
8
Tanzania
8
Ethiopia
7
Philippines
7
Syria
7
South Africa
7
Malawi
7
Zimbabwe
6
Nepal
6
Indonesia
6
Congo, Democratic Republic of
5
Bangladesh
5
Western and Central Europe
5
Senegal
4
Cameroon
4
Rwanda
4
Botswana
4
Myanmar / Burma
4
Venezuela
4
Haiti
3
Mozambique
3
Lesotho
3
Latin America and the Carribbean
3
Eastern Europe
3
Pakistan
2
Germany
2
Papua New Guinea
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Africa
2
Albania
2
Burkina Faso
1
Mali
1
Niger
1
South Sudan
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
China
1
Sudan
1
Central African Republic
1
North Macedonia
1
Libya
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Mongolia
1
Southern Africa
1
Laos
1
Bulgaria
1
Lithuania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
198
Clinical Guidelines
35
Public Health
18
Pharmacy & Technologies
12
Key Resources
8
Women & Child Health
7
Capacity Building
2
Toolboxes
Pharmacy
57
AMR
42
COVID-19
40
HIV
39
Mental Health
30
TB
15
Global Health Education
12
Health Financing Toolbox
11
Conflict
10
Planetary Health
8
NTDs
7
NCDs
7
Caregiver
5
Ebola
4
Rapid Response
4
Disability
3
Refugee
3
Polio
2
Cholera
1
Natural Hazards
1
Health Financing
1
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac
...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand
...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function
...
High prices, hard-to-access human insulin, few insulin producers, and weak health systems are just some of the barriers that people with diabetes face a century after insulin was discovered, WHO notes in a new report
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The Ethiopian Hospital Services Transformation Guidelines (EHSTG) build on and expand the Ethiopian Hospital Reform Implementation Guidelines (EHRIG) and are consistent with the Health Sector Transformation Plan (HSTP). The EHSTG, which is consistent with the national focu
...
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed wh
...
